Specific glucocorticosteroid compound having antiinflammatory activity

Details for Australian Patent Application No. 2004255854 (hide)

Owner Glaxo Group Limited

Inventors John, Matthew Peter; Needham, Deborah; Biggadike, Keith

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004255854

PCT Pub. Number WO2005/005451

Priority 0316290.6 11.07.03 GB

Filing date 9 July 2004

Wipo publication date 20 January 2005

Acceptance publication date 22 October 2009

International Classifications

A61P 5/44 (2006.01) Drugs for disorders of the endocrine system

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

C07J 3/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/005451 Priority application(s): WO2005/005451

22 October 2009 Application Accepted

  Published as AU-B-2004255854

18 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255855-Specific glucocorticosteroid compound having antiinflammatory activity

2004255835-Sensing device